Highest-materiality recent filing
Natural Health Trends Q2 revenue down 23% to $7.6M; net loss of $0.05 per share
Revenue $7.6M, down 23% YoY; operating loss $643K vs $333K loss in Q2 2025.
Approved 2026 Equity Incentive Plan authorizing up to 1,100,000 shares of common stock for equity awards.
NHTC Q1 2026 revenue $9.2M, down 14% YoY; net loss $154k vs prior year income
Revenue $9.2M, down 6% from Q4 2025 and 14% from Q1 2025.
NHTC repurchases all Broady family shares (~25.5% of outstanding) for $5.9M
Repurchased 2,935,227 shares (25.5% of outstanding) from George K. Broady trusts for $2.00/share, total $5.9M cash.
Natural Health Trends Q4 revenue $9.7M, net loss $0.05/share; full year revenue down 7%
Q4 revenue $9.7M, down 10% YoY but up 3% sequentially; net loss $588K ($0.05 diluted EPS).
Natural Health Trends Q3 loss widens; revenue down 11%; plans restructuring, dividend cut
Revenue $9.5M (-11% YoY); net loss $0.04/diluted share vs breakeven prior year.
NHTC Q2 2025 revenue $9.8M (-6% YoY); net income $15K vs $173K; dividend $0.20
Revenue $9.8M, down 6% from $10.5M in Q2 2024.
Natural Health Trends Q3 revenue down 9% to $10.6M; net income $172k; declares $0.20 dividend
Revenue $10.6M, down 9% YoY; operating loss $292k vs $145k loss in Q3 2022.
Natural Health Trends Q2 revenue down 21% to $10.5M; posts net loss of $0.02 per share
Revenue $10.5M vs $13.4M YoY (-21%); operating loss $743K vs income $215K.
Natural Health Trends Q1 revenue $11.9M (+3% YoY); first revenue increase since Q3 2021
Net income $257K ($0.02 diluted EPS) vs loss $105K ($0.01 loss) in Q1 2022; operating loss $394K.
Q4 2022 revenue $12.5M, up 7% from Q3 but down 22% YoY; net income $188K ($0.02 diluted EPS).
NHTC Q3 revenue down 18% YoY to $11.7M; declares $0.20 dividend
Revenue $11.7M vs $14.3M YoY (-18%); operating loss of $145K vs income $479K.
NHTC Q2 revenue down 17% YoY to $13.4M; net income $183K; declares $0.20 dividend
Revenue $13.4M, -17% YoY but +16% sequential; operating income $215K vs loss in Q1.
Natural Health Trends Q1 revenue down 14% to $11.5M; posts operating loss
Revenue $11.5M, down 14% YoY from $13.5M.
Natural Health Trends Q3 revenue flat YoY at $14.3M; SEC and IRS investigations closed
Q3 2021 revenue $14.3M (+1% YoY); net income $471k ($0.04 diluted EPS).
SEC investigation of Natural Health Trends closed with no enforcement action
SEC notified company on Sept 30, 2021, that investigation concluded with no recommended enforcement action.
NHTC Q2 rev $16.2M (+20% QoQ), net income $229K; declares $0.20/share dividend
Revenue $16.2M, up 20% from Q1 2021 but down 2% YoY from $16.4M.
On July 29, 2024, the Board of Directors of the Company, upon the recommendation of the Company's Nominating and Corporate Governance Committee, expanded the size of the Board of Directors to five (5) members and elected Lucy Nduati as a director to fill the newly created directorship.
Brunde E. Broady resigned as a member of the Board of Directors on February 6, 2023, stating that her resignation was due to unforeseen circumstances in her personal life.
Max materiality 0.80 · Median 0.55 · Most common event earnings